Somatic mutations in the HLA genes of patients with hematological malignancy

Tissue Antigens

Volumn 79, Issue 5, 2012, Pages 359-366

  Smith, A G ^a   Fan, W ^a   Regen, L ^b   Warnock, S ^b   Sprague, M ^b   Williams, R ^b   Nisperos, B ^b   Zhao, L P ^a   Loken, M R ^c   Hansen, J A ^a,d   Pereira, S ^a,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

^c HEMATOLOGICS INC   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hematological malignancy; Human leukocyte antigen mutations; Loss of expression; Loss of heterozygosity; Somatic mutation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DONOR SELECTION; GENE EXPRESSION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOSITY LOSS; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; LEUKEMIA RELAPSE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD; SOMATIC MUTATION;

ADULT; CHILD; HAPLOTYPES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; LEUKEMIA; LOSS OF HETEROZYGOSITY; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC;

EID: 84859585621     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01868.x     Document Type: Article

References (18)

1. Ley TJ, Mardis ER, Ding L et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008: 456: 66-72.
2. O'Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies (Review). Blood 2010: 115: 2731-9.
3. Smith AG, Sprague M, Peterson P et al. Detection of an acquired mutation in an HLA-A*03 allele impairing gene expression in leukemia cells of a patient with ALL. Hum Immunol 2002: 63 (Suppl): S1, # 1.1 (abstract).
4. Sayer DC, Smith LK, Krueger R, Chrisitansen FT. DNA sequencing-based HLA typing detects a B-cell ALL blast-specific mutation in HLA-A(*)2402 resulting in loss of HLA allele expression. Leukemia 2004: 18: 174-6.
5. Pereira SE, Vayntrub T, Hiraki D, Grumet CF. STR size mutation or loss of heterozygosity at different loci confound engraftment and typing analysis, a phenomenon prevalent in AML. Hum Immunol 2005: 66 (Suppl): S32, #3, 40-p (abstract)
6. Pereira S, Vayntrub T, Hiraki DD et al. Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants. Hum Immunol 2011: 72: 503-9.
7. Gaidulis L, Sun J-Y, Senitzer D. The case of a homozygous heterozygote. Hum Immunol 2005: 66 (Suppl): S24, #2, 25-W (abstract).
8. Gaidulis L, Sun J, Senitzer D. Loss of HLA and STR alleles observed in a patient during blast crisis. Hum Immunol 2007: 68: (Suppl): S130, #59-W (abstract).
9. Fernandez-Vina M, Garcia-Manero G, Cortes J, Abruzzo L, Cano P. Typing the malignant clone vs the patient's tissue. Hum Immunol 2007: 68 (Suppl): S131, #60-W (abstract).
10. Cano P, Guerrero E, Partlow E, Willis D, Zhao W, Fernandez-Vina M. HLA mutations in leukaemia cells show selective preference for Bw6 alleles avoiding NK-cell-related immunosurveillance. Hum Immunol 2009: 70 (Suppl): S6, #12-W (abstract).
11. Smith AG, Warnock S, McKinney S, Regen L, Hansen JA. A transplant center experience with somatic mutations in the HLA genes of patients with malignant hematologic diseases or a myelodysplastic syndrome (MDS). Hum Immunol 2008: 69 (Suppl): S130, #58-W (abstract).
12. Campoli M, Cheney R, Rebmann V et al. HLA antigen changes and cancer: a report from the 13th International Histocompatibility Workshop. In: Hansen JA, ed. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatability Workshop and Conference, Vol. 1. Seattle: Histocompatibility Working Group Press, 2006, 833-46.
13. Aptsiauri N, Cabrera T, Lora AG, Ruiz-Cabello F, Garrido F. HLA class I expression, tumor escape and cancer progression. Curr Cancer Ther Rev 2008: 4: 105-10.
14. Demanet C, Mulder A, Deneys V et al. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood 2004: 103: 3122-30.
15. Vago L, Perna SK, Zanussi M et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 2009: 361: 478-88.
16. Villalobos IB, Takahashi Y, Akatsuka Y et al. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. Blood 2010: 115: 3158-61.
17. Wells DA, Sale GE, Shulman HM et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998: 110: 84-94.
18. Smith AG, McFarland C, Hertenstein H et al. Hemizygosity detected at 13 of 14 VNTR/STR loci in CD45/19+ leukemia cells from a patient with ALL. Hum Immunol 2002: 63 (Suppl): S27, #6.2 (abstract).